OPCH vs LFST
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
OPCH · Option Care Health$31.65 ▲ 0.48%
LFST · LifeStance Health$13.77 ▲ 2.53%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- OPCH +12.3%
- LFST +114.2%
Head to head
| Metric | OPCH | LFST |
|---|---|---|
| Price | $31.65 | $13.77 |
| Change today | ▲ 0.48% | ▲ 2.53% |
| Market cap | $4.74B | $5.24B |
| Return, 3 months | +29.2% | +15.7% |
| Return, year to date | -0.7% | +95.6% |
| Return, 1 year | +14.5% | +118.9% |
| P/E (TTM) | 22.9 | 76.5 |
| P/B | 3.6 | 3.5 |
| P/E percentile vs own 5y | 40th | 91st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +1.9% | +26.1% |
| Net profit growth (YoY) | +6.7% | +722.8% |
| Gross margin | 19.1% | 33.6% |
| Operating margin | 5.9% | 4.9% |
| Net margin | 3.7% | 3.2% |
| Return on equity | 16.0% | 3.4% |
| Analyst target vs. price | +2.0% | +6.2% |
| Analyst buy share | 29% | 89% |
| RSI (14) | 76 | 62 |
| 30-day volatility | 82.5% | 37.8% |
| Max drawdown, 1 year | -46.7% | -17.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LFST is the largest of the group by market value.
- LFST has returned the most over the past year.
- OPCH carries the lowest trailing P/E.
- LFST is growing revenue fastest.
- OPCH keeps the most profit per dollar of sales.
- LFST has been the calmest stock over the last 30 days.